Cargando…
Less invasive surfactant administration (LISA): chances and limitations
Non-invasive ventilation and especially the application of continuous positive airway pressure (CPAP) has become standard for the treatment of premature infants with respiratory problems. However, CPAP failure may occur due to respiratory distress syndrome, that is, surfactant deficiency. Less invas...
Autores principales: | Herting, Egbert, Härtel, Christoph, Göpel, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855838/ https://www.ncbi.nlm.nih.gov/pubmed/31296694 http://dx.doi.org/10.1136/archdischild-2018-316557 |
Ejemplares similares
-
Less invasive surfactant administration: best practices and unanswered questions
por: Herting, Egbert, et al.
Publicado: (2020) -
A randomised controlled trial in preterm infants comparing prophylactic with selective “less invasive surfactant administration” (pro.LISA)
por: Göpel, Wolfgang, et al.
Publicado: (2023) -
Less invasive surfactant administration and complications of preterm birth
por: Härtel, Christoph, et al.
Publicado: (2018) -
Two-year outcome data suggest that less invasive surfactant administration (LISA) is safe. Results from the follow-up of the randomized controlled AMV (avoid mechanical ventilation) study
por: Herting, Egbert, et al.
Publicado: (2020) -
Association of Administration of Surfactant Using Less Invasive Methods With Outcomes in Extremely Preterm Infants Less Than 27 Weeks of Gestation
por: Härtel, Christoph, et al.
Publicado: (2022)